Genistein, in the glioma cell line U87MG at a dose of 10 μM, increases the arrest of the G2/M cell cycle and cellular apoptosis by downregulating the protein levels of MT1‐MMP and uPAR, as well as MMP‐2 and MMP‐9.173. The gene discussed is MMP2; the disease is central nervous system cancer.